P
PT UBC Medical Indonesia Tbk
IDX:LABS
PT UBC Medical Indonesia Tbk
IDX:LABS
Price:
150
IDR
0.67%
Market Closed
Market Cap:
Rp592.5B
Income Statement
Earnings Waterfall
PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk
Income Statement
PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk
Currency: IDR
| Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
181 100
N/A
|
169 799
-6%
|
176 644
+4%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(108 352)
|
(106 562)
|
(108 700)
|
|
| Gross Profit |
72 748
N/A
|
63 237
-13%
|
67 944
+7%
|
|
| Operating Income | ||||
| Operating Expenses |
(59 901)
|
(49 839)
|
(52 219)
|
|
| Selling, General & Administrative |
(41 286)
|
(36 178)
|
(37 603)
|
|
| Depreciation & Amortization |
(15 416)
|
(10 880)
|
(11 992)
|
|
| Other Operating Expenses |
(3 199)
|
(2 780)
|
(2 624)
|
|
| Operating Income |
12 847
N/A
|
13 399
+4%
|
15 725
+17%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(5 365)
|
(1 958)
|
(3 442)
|
|
| Gain/Loss on Disposition of Assets |
140
|
232
|
140
|
|
| Total Other Income |
(483)
|
(1 093)
|
(784)
|
|
| Pre-Tax Income |
7 138
N/A
|
10 579
+48%
|
11 639
+10%
|
|
| Net Income | ||||
| Tax Provision |
(2 337)
|
0
|
0
|
|
| Income from Continuing Operations |
4 801
|
8 242
|
9 302
|
|
| Income to Minority Interest |
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
4 801
N/A
|
8 242
+72%
|
9 302
+13%
|
|
| EPS (Diluted) |
1.22
N/A
|
2.09
+71%
|
2.36
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
